BioSpecifics Reports Second Quarter 2020 Financial and Operating Results

Author's Avatar
Aug 10, 2020
Article's Main Image

- Highly experienced business development executive, Alex Monteith, named as Senior Vice President and Chief Business Officer

- Qwo™ (collagenase clostridium histolyticum-aaes) approved by FDA for treatment of cellulite

- Patient dosing initiated in clinical trials for XIAFLEX® in both plantar fibromatosis and adhesive capsulitis

PR Newswire